These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24364505)

  • 1. A further validation of the Minnesota Borderline Personality Disorder Scale.
    Rojas EC; Cummings JR; Bornovalova MA; Hopwood CJ; Racine SE; Keel PK; Sisk CL; Neale M; Boker S; Burt SA; Klump KL
    Personal Disord; 2014 Apr; 5(2):146-153. PubMed ID: 24364505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elaborating on the construct validity of the Minnesota Borderline Personality Disorder Scale (MBPD): a multi-sample, longitudinal examination.
    Rojas EC; Hicks BM; Stark S; Hopwood CJ; Bornovalova MA
    Psychol Assess; 2015 Mar; 27(1):332-9. PubMed ID: 25558963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the Minnesota borderline personality disorder scale.
    Bornovalova MA; Hicks BM; Patrick CJ; Iacono WG; McGue M
    Assessment; 2011 Jun; 18(2):234-52. PubMed ID: 21467094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline personality disorder in adolescents: evidence in support of the Childhood Interview for DSM-IV Borderline Personality Disorder in a sample of adolescent inpatients.
    Sharp C; Ha C; Michonski J; Venta A; Carbone C
    Compr Psychiatry; 2012 Aug; 53(6):765-74. PubMed ID: 22300904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Personality Disorder Interview for DSM-IV (PDI-IV) and SCID-II borderline personality disorder scales: an item-response theory analysis.
    Huprich SK; Paggeot AV; Samuel DB
    J Pers Assess; 2015; 97(1):13-21. PubMed ID: 25203418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.
    Zanarini MC; Vujanovic AA; Parachini EA; Boulanger JL; Frankenburg FR; Hennen J
    J Pers Disord; 2003 Jun; 17(3):233-42. PubMed ID: 12839102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergence between DSM-5 Section II and Section III diagnostic criteria for borderline personality disorder.
    Sellbom M; Sansone RA; Songer DA; Anderson JL
    Aust N Z J Psychiatry; 2014 Apr; 48(4):325-32. PubMed ID: 24253360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing External Correlates of DSM-5 Section II and Section III Dimensional Trait Operationalizations of Borderline Personality Disorder.
    Anderson JL; Sellbom M; Sansone RA; Songer DA
    J Pers Disord; 2016 Apr; 30(2):193-210. PubMed ID: 25905733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of a Chinese version of the Diagnostic Interview for Borderlines-Revised.
    Wang L; Yuan C; Qiu J; Gunderson J; Zhang M; Jiang K; Leung F; Zhong J; Xiao Z
    Asia Pac Psychiatry; 2014 Sep; 6(3):326-33. PubMed ID: 24302703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuity between DSM-5 Categorical Criteria and Traits Criteria for Borderline Personality Disorder.
    Bach B; Sellbom M
    Can J Psychiatry; 2016 Aug; 61(8):489-94. PubMed ID: 27310232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short screening tool for borderline personality disorder (Short-Bord): Validated by Rasch analysis.
    Wongpakaran N; Wongpakaran T; Kuntawong P
    Asian J Psychiatr; 2019 Aug; 44():195-199. PubMed ID: 31415930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the Borderline Symptom List to DSM-IV borderline personality disorder criteria assessed by semi-structured interview.
    Glenn CR; Weinberg A; Klonsky ED
    Psychopathology; 2009; 42(6):394-8. PubMed ID: 19776670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construct Validity of the DSM-5 Section III Personality Trait Profile for Borderline Personality Disorder.
    Anderson JL; Sellbom M
    J Pers Assess; 2015; 97(5):478-86. PubMed ID: 26061018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening measure for borderline personality disorder].
    Kröger C; Vonau M; Kliem S; Kosfelder J
    Psychother Psychosom Med Psychol; 2010; 60(9-10):391-6. PubMed ID: 20225166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the French version of the McLean screening instrument for borderline personality disorder (MSI-BPD) in an adolescent sample.
    Mirkovic B; Speranza M; Cailhol L; Guelfi JD; Perez-Diaz F; Corcos M; Robin M; Pham-Scottez A
    BMC Psychiatry; 2020 May; 20(1):222. PubMed ID: 32398037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An item response theory analysis of the DSM-IV borderline personality disorder criteria in a population-based sample of 11- to 12-year-old children.
    Michonski JD; Sharp C; Steinberg L; Zanarini MC
    Personal Disord; 2013 Jan; 4(1):15-22. PubMed ID: 22642465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of genetic and environmental risk factors for symptoms of DSM-IV borderline personality disorder.
    Reichborn-Kjennerud T; Ystrom E; Neale MC; Aggen SH; Mazzeo SE; Knudsen GP; Tambs K; Czajkowski NO; Kendler KS
    JAMA Psychiatry; 2013 Nov; 70(11):1206-14. PubMed ID: 24048243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline personality disorder subscale (Chinese version) of the structured clinical interview for DSM-IV axis II personality disorders: a validation study in Cantonese-speaking Hong Kong Chinese.
    Wong HM; Chow LY
    East Asian Arch Psychiatry; 2011 Jun; 21(2):52-7. PubMed ID: 21838207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline personality-bipolar spectrum relationship.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):68-74. PubMed ID: 16019119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating borderline personality from bipolar disorder with the Mood Disorder Questionnaire (MDQ): A replication and extension of the International Mood Network (IMN) Nosology Project.
    Balling C; Chelminski I; Dalrymple K; Zimmerman M
    Compr Psychiatry; 2019 Jan; 88():49-51. PubMed ID: 30502595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.